Article
Give us your opinion on our latest poll, and see what your colleagues are saying. You can see the results of our previous surveys here as well.
Floppy iris syndrome risk: Study finds women more susceptible, key drugs identified
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Iantrek announces positive 2-year results from clinical study of its bio-interventional platform for uveoscleral outflow enhancement
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Ocugen to move forward with dosing of second cohort of phase 1 clinical trial of OCU200
Formosa Pharmaceuticals enters into licensing agreement with Cipla for commercialization of APP13007 across 11 countries